Upcoming Webinars
-
FDA QSR to QMSR: Regulatory, Legal, and Risk Implications for Industry
In this webinar, Denise Holliday, Expert Witness at Capwell Consulting Group, helps you understand how the transition to QMSR may affect regulatory compliance, product liability exposure, and organizational risk.
Register for FDA QSR to QMSR: Regulatory, Legal, and Risk Implications for Industry Read More about FDA QSR to QMSR: Regulatory, Legal, and Risk Implications for Industry
Past Webinars
-
State of the Medtech Industry
Join Tony Freeman from A.S. Freeman Advisors LLC, as he gives an overview of the medical technology industry with an emphasis on the economic, demographic, and technological trends that are currently reshaping product offerings.
Read More about State of the Medtech Industry -
FDA Policies: Reflecting on the Past, Understanding the Present, and Preparing for the Future
Join Rick Quinn and Jennifer Diaz from Diaz Trade Law as they discuss FDA Policies: Reflecting on the Past, Understanding the Present, and Preparing for the Future.
Read More about FDA Policies: Reflecting on the Past, Understanding the Present, and Preparing for the Future -
Private Labeling of Medical Devices in the U.S.
Join Sarah Lacey Robbins from RookQS as she discusses Private Labeling of Medical Devices in the U.S.
Read More about Private Labeling of Medical Devices in the U.S. -
Medical Device v2.0: Safer but Riskier?
Join Clark Hill PLC Member Matt Marshall as he discusses the requirements of GMP relating to product improvement, the potential risks of such improvements in litigation, and how such improvements may run afoul of a device’s existing FDA clearance.
Read More about Medical Device v2.0: Safer but Riskier?